STOCK TITAN

[Form 4] Alpha Cognition Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Alpha Cognition director Robert Wills purchased 15,000 shares of common stock in open market transactions on 08/18/2025. The filing shows a weighted average price of $8.4885 per share, with individual trade prices ranging from $8.15 to $8.86. After the purchases the reporting person beneficially owns 15,000 shares. The Form 4 was filed by one reporting person and identifies the purchase as an open market acquisition; the filer agrees to provide transaction-level price details on request.

Il direttore di Alpha Cognition, Robert Wills, ha acquistato 15.000 azioni ordinarie in operazioni sul mercato aperto il 18/08/2025. La comunicazione indica un prezzo medio ponderato di $8,4885 per azione, con singole esecuzioni che vanno da $8,15 a $8,86. Dopo gli acquisti, la persona che presenta il rapporto possiede beneficiariamente 15.000 azioni. Il Modulo 4 è stato presentato da un unico soggetto segnalante e identifica l’acquisto come un’acquisizione sul mercato aperto; il dichiarante si impegna a fornire, su richiesta, i dettagli dei prezzi a livello di singola transazione.

El director de Alpha Cognition, Robert Wills, compró 15.000 acciones ordinarias en transacciones en el mercado abierto el 18/08/2025. La presentación muestra un precio medio ponderado de $8,4885 por acción, con precios individuales que van desde $8,15 hasta $8,86. Tras las compras, la persona informante posee beneficiariamente 15.000 acciones. El Formulario 4 fue presentado por una sola persona informante y describe la compra como una adquisición en el mercado abierto; el declarante acepta proporcionar, a petición, los detalles de precio por transacción.

Alpha Cognition의 디렉터 로버트 윌스는 2025년 8월 18일 장내 거래로 보통주 15,000주를 매수했습니다. 제출 서류에는 주당 가중평균가격이 $8.4885로 표시되어 있으며, 개별 거래 가격은 $8.15에서 $8.86 사이입니다. 매수 후 보고인은 실질적으로 15,000주를 보유하게 됩니다. Form 4는 단일 보고인이 제출했으며 이번 매수를 장내 취득으로 규정하고 있습니다; 제출인은 요청 시 개별 거래별 가격 내역을 제공하기로 동의했습니다.

Le directeur d'Alpha Cognition, Robert Wills, a acheté 15 000 actions ordinaires lors d'opérations de marché ouvert le 18/08/2025. Le dépôt indique un prix moyen pondéré de 8,4885 $ par action, les prix des transactions individuelles allant de 8,15 $ à 8,86 $. Après ces achats, la personne déclarante détient bénéficiairement 15 000 actions. Le formulaire 4 a été déposé par une seule personne déclarante et qualifie l'achat d'acquisition sur le marché ouvert ; le déclarant accepte de fournir, sur demande, le détail des prix au niveau de chaque transaction.

Alpha Cognition-Direktor Robert Wills erwarb am 18.08.2025 im Handel 15.000 Stammaktien. Die Meldung weist einen gewichteten Durchschnittspreis von $8,4885 je Aktie aus, wobei die Einzelpreise zwischen $8,15 und $8,86 lagen. Nach den Käufen besitzt die meldende Person wirtschaftlich 15.000 Aktien. Das Formular 4 wurde von einer meldenden Person eingereicht und bezeichnet den Erwerb als Offenmarkttransaktion; der Meldende erklärt sich bereit, auf Anfrage Transaktionspreisdetails auf Einzelebene zur Verfügung zu stellen.

Positive
  • Director Robert Wills executed an open-market purchase of 15,000 shares
  • Filing discloses weighted average price $8.4885 and price range $8.15–$8.86
  • Reporting person confirms willingness to provide per-trade price details on request
Negative
  • None.

Insights

TL;DR: Director bought 15,000 shares at a weighted average $8.4885 on 08/18/2025; routine open-market insider purchase.

The Form 4 documents an open-market acquisition totaling 15,000 common shares at a reported weighted average price of $8.4885, with trade prices between $8.15 and $8.86. The filing shows the reporter is a director and the transaction was executed on 08/18/2025. The disclosure indicates the reporting person will provide per-trade pricing if requested, which clarifies the weighted average notation. From a reporting and valuation perspective, the entry is straightforward and provides clear quantitative detail on the director's incremental stake.

TL;DR: Director-level open market purchase disclosed; Form 4 properly reports beneficial ownership change and price range.

The filing identifies Robert Wills as a director and reports the acquisition method as open market purchases. The Form 4 lists the total shares acquired and the beneficially owned shares following the transaction, and includes the mandated statement offering to supply trade-by-trade prices on request. The document complies with Section 16 reporting norms by disclosing transaction date, aggregate amount, and weighted average price, with a manual signature dated 08/20/2025.

Il direttore di Alpha Cognition, Robert Wills, ha acquistato 15.000 azioni ordinarie in operazioni sul mercato aperto il 18/08/2025. La comunicazione indica un prezzo medio ponderato di $8,4885 per azione, con singole esecuzioni che vanno da $8,15 a $8,86. Dopo gli acquisti, la persona che presenta il rapporto possiede beneficiariamente 15.000 azioni. Il Modulo 4 è stato presentato da un unico soggetto segnalante e identifica l’acquisto come un’acquisizione sul mercato aperto; il dichiarante si impegna a fornire, su richiesta, i dettagli dei prezzi a livello di singola transazione.

El director de Alpha Cognition, Robert Wills, compró 15.000 acciones ordinarias en transacciones en el mercado abierto el 18/08/2025. La presentación muestra un precio medio ponderado de $8,4885 por acción, con precios individuales que van desde $8,15 hasta $8,86. Tras las compras, la persona informante posee beneficiariamente 15.000 acciones. El Formulario 4 fue presentado por una sola persona informante y describe la compra como una adquisición en el mercado abierto; el declarante acepta proporcionar, a petición, los detalles de precio por transacción.

Alpha Cognition의 디렉터 로버트 윌스는 2025년 8월 18일 장내 거래로 보통주 15,000주를 매수했습니다. 제출 서류에는 주당 가중평균가격이 $8.4885로 표시되어 있으며, 개별 거래 가격은 $8.15에서 $8.86 사이입니다. 매수 후 보고인은 실질적으로 15,000주를 보유하게 됩니다. Form 4는 단일 보고인이 제출했으며 이번 매수를 장내 취득으로 규정하고 있습니다; 제출인은 요청 시 개별 거래별 가격 내역을 제공하기로 동의했습니다.

Le directeur d'Alpha Cognition, Robert Wills, a acheté 15 000 actions ordinaires lors d'opérations de marché ouvert le 18/08/2025. Le dépôt indique un prix moyen pondéré de 8,4885 $ par action, les prix des transactions individuelles allant de 8,15 $ à 8,86 $. Après ces achats, la personne déclarante détient bénéficiairement 15 000 actions. Le formulaire 4 a été déposé par une seule personne déclarante et qualifie l'achat d'acquisition sur le marché ouvert ; le déclarant accepte de fournir, sur demande, le détail des prix au niveau de chaque transaction.

Alpha Cognition-Direktor Robert Wills erwarb am 18.08.2025 im Handel 15.000 Stammaktien. Die Meldung weist einen gewichteten Durchschnittspreis von $8,4885 je Aktie aus, wobei die Einzelpreise zwischen $8,15 und $8,86 lagen. Nach den Käufen besitzt die meldende Person wirtschaftlich 15.000 Aktien. Das Formular 4 wurde von einer meldenden Person eingereicht und bezeichnet den Erwerb als Offenmarkttransaktion; der Meldende erklärt sich bereit, auf Anfrage Transaktionspreisdetails auf Einzelebene zur Verfügung zu stellen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Wills Robert James

(Last) (First) (Middle)
C/O ALPHA COGNITION INC.
1452 HUGHES RD., STE. 200

(Street)
GRAPEVINE TX 76051

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Alpha Cognition Inc. [ ACOG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/18/2025 P(1) 15,000 A $8.4885(2) 15,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Open market purchase.
2. The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.15 to $8.86 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
/s/ Robert Wills 08/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Alpha Cognition (ACOG) director Robert Wills report?

He reported an open-market purchase of 15,000 common shares on 08/18/2025 as disclosed on the Form 4.

At what price did the insider purchases occur for ACOG?

The Form 4 reports a weighted average price of $8.4885 per share, with individual trades ranging from $8.15 to $8.86.

How many shares does the reporting person beneficially own after the transaction?

The filing shows the reporting person beneficially owns 15,000 shares following the reported transaction.

When was the Form 4 transaction dated and when was it signed?

The transaction date is 08/18/2025 and the Form 4 bears the reporting person’s signature dated 08/20/2025.

Did the Form 4 indicate the purchase method or any special plan?

Yes. The Form 4 identifies the acquisition as an open market purchase and does not indicate a Rule 10b5-1 plan.
Alpha Cognition

NASDAQ:ACOG

ACOG Rankings

ACOG Latest News

ACOG Latest SEC Filings

ACOG Stock Data

128.08M
13.91M
13.05%
35.39%
0.8%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
Canada
VANCOUVER